The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
Open accessAbstract
Myeloma is a malignant proliferation of monoclonal plasma cells. Although morphologically similar, several subtypes of the disease have been identified at the genetic and molecular level. These genetic subtypes are associated with unique clinicopathological features and dissimilar outcome. At the top hierarchical level, myeloma can be divided into hyperdiploid and non-hyperdiploid subtypes. The latter is mainly composed of cases harboring IgH translocations, generally associated with more aggressive clinical features and shorter survival. The three main IgH translocations in myeloma are the t(11;14)(q13;q32), t(4;14)(p16;q32) and t(14;16)(q32;q23). Trisomies and a more indolent form of the disease characterize hyperdiploid myeloma. A number of genetic progression factors have been identified including deletions of chromosomes 13 and 17 and abnormalities of chromosome 1 (1p deletion and 1q amplification). Other key drivers of cell survival and proliferation have also been identified such as nuclear factor- B-activating mutations and other deregulation factors for the cyclin-dependent pathways regulators. Further understanding of the biological subtypes of the disease has come from the application of novel techniques such as gene expression profiling and array-based comparative genomic hybridization. The combination of data arising from these studies and that previously elucidated through other mechanisms allows for most myeloma cases to be classified under one of several genetic subtypes. This paper proposes a framework for the classification of myeloma subtypes and provides recommendations for genetic testing. This group proposes that genetic testing needs to be incorporated into daily clinical practice and also as an essential component of all ongoing and future clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
San Miguel, J. F., Schlag, R., Khuageva, N. K., Dimopoulos, M. A., Shpilberg, O., Kropff, M., Spicka, I., Petrucci, M. T., Palumbo, A., Samoilova, O. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801479 · Cited by 1,899
Kyle, R. A., & Rajkumar, S. V. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041875 · Cited by 1,296
The molecular classification of multiple myeloma
Zhan, F., Huang, Y., Colla, S., Stewart, J. P., Hanamura, I., Gupta, S., Epstein, J., Yaccoby, S., Sawyer, J., Burington, B., et al. (2006) · Blood · doi:10.1182/blood-2005-11-013458 · Cited by 1,133
Self-citationPromiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
Self-citationAnnunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
Self-citationShaughnessy, J. D., Zhan, F., Burington, B. E., Huang, Y., Colla, S., Hanamura, I., Stewart, J. P., Kordsmeier, B., Randolph, C., Williams, D. R., et al. (2007) · Blood · doi:10.1182/blood-2006-07-038430 · Cited by 914
Self-citationAvet-Loiseau, H., Attal, M., Moreau, P., Charbonnel, C., Garban, F., Hulin, C., Leyvraz, S., Michallet, M., Yakoub-Agha, I., Garderet, L., et al. (2007) · Blood · doi:10.1182/blood-2006-08-040410 · Cited by 911
Self-citationMultiple myeloma: evolving genetic events and host interactions
Kuehl, W. M., & Bergsagel, P. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc746 · Cited by 818
Self-citationCyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma
Bergsagel, P. L., Kuehl, W. M., Zhan, F., Sawyer, J., Barlogie, B., & Shaughnessy, J. (2005) · Blood · doi:10.1182/blood-2005-01-0034 · Cited by 698
Self-citationClinical and biologic implications of recurrent genomic aberrations in myeloma
Fonseca, R., Blood, E., Rue, M., Harrington, D., Oken, M. M., Kyle, R. A., Dewald, G. W., Van Ness, B., Van Wier, S. A., Henderson, K. J., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3017 · Cited by 660
Self-citationChesi, M., Nardini, E., Brents, L. A., Schröck, E., Ried, T., Kuehl, W. M., & Bergsagel, P. L. (1997) · Nature Genetics · doi:10.1038/ng0797-260 · Cited by 637
Self-citationLöffler, D., Brocke-Heidrich, K., Pfeifer, G., Stocsits, C., Hackermüller, J., Kretzschmar, A. K., Burger, R., Gramatzki, M., Blumert, C., Bauer, K., et al. (2007) · Blood · doi:10.1182/blood-2007-03-081133 · Cited by 637
Chesi, M., Nardini, E., Lim, R. S. C., Smith, K. D., Kuehl, W. M., & Bergsagel, P. L. (1998) · Blood · doi:10.1182/blood.v92.9.3025 · Cited by 572
Self-citationMicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
Pichiorri, F., Suh, S.-S., Ladetto, M., Kuehl, M., Palumbo, T., Drandi, D., Taccioli, C., Zanesi, N., Alder, H., Hagan, J. P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806202105 · Cited by 563
Hanamura, I., Stewart, J. P., Huang, Y., Zhan, F., Santra, M., Sawyer, J. R., Hollmig, K., Zangarri, M., Pineda-Roman, M., van Rhee, F., et al. (2006) · Blood · doi:10.1182/blood-2006-03-009910 · Cited by 479
Self-citationCarrasco, D. R., Tonon, G., Huang, Y., Zhang, Y., Sinha, R., Feng, B., Stewart, J. P., Zhan, F., Khatry, D., Protopopova, M., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.019 · Cited by 425
Self-citationTricot, G., Barlogie, B., Jagannath, S., Bracy, D., Mattox, S., Vesole, D., Naucke, S., & Sawyer, Jr. (1995) · Blood · doi:10.1182/blood.v86.11.4250.bloodjournal86114250 · Cited by 395
Self-citationMateos, M.-V., Hernández, J.-M., Hernández, M.-T., Gutiérrez, N.-C., Palomera, L., Fuertes, M., Díaz-Mediavilla, J., Lahuerta, J.-J., de la Rubia, J., Terol, M.-J., et al. (2006) · Blood · doi:10.1182/blood-2006-04-019778 · Cited by 389
Self-citationKeats, J. J., Reiman, T., Maxwell, C. A., Taylor, B. J., Larratt, L. M., Mant, M. J., Belch, A. R., & Pilarski, L. M. (2003) · Blood · doi:10.1182/blood-2002-06-1675 · Cited by 382
Self-citationGertz, M. A. (2005) · Blood · doi:10.1182/blood-2005-04-1411 · Cited by 360
Avet-Loiseau, H., Facon, T., Grosbois, B., Magrangeas, F., Rapp, M.-J., Harousseau, J.-L., Minvielle, S., & Bataille, R. (2002) · Blood · doi:10.1182/blood.v99.6.2185 · Cited by 358
Self-citationGenetic aberrations and survival in plasma cell leukemia
Tiedemann, R. E., Gonzalez-Paz, N., Kyle, R. A., Santana-Davila, R., Price-Troska, T., Van Wier, S. A., Chng, W. J., Ketterling, R. P., Gertz, M. A., Henderson, K., et al. (2008) · Leukemia · doi:10.1038/leu.2008.4 · Cited by 349
Self-citationGenomic abnormalities in monoclonal gammopathy of undetermined significance
Fonseca, R., Bailey, R. J., Ahmann, G. J., Rajkumar, S. V., Hoyer, J. D., Lust, J. A., Kyle, R. A., Gertz, M. A., Greipp, P. R., & Dewald, G. W. (2002) · Blood · doi:10.1182/blood.v100.4.1417.h81602001417_1417_1424 · Cited by 348
Self-citationMyeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients
Fonseca, R., Blood, E. A., Oken, M. M., Kyle, R. A., Dewald, G. W., Bailey, R. J., Van Wier, S. A., Henderson, K. J., Hoyer, J. D., Harrington, D., et al. (2002) · Blood · doi:10.1182/blood.v99.10.3735 · Cited by 340
Self-citationDrach, J., Ackermann, J., Fritz, E., Krömer, E., Schuster, R., Gisslinger, H., DeSantis, M., Zojer, N., Fiegl, M., Roka, S., et al. (1998) · Blood · doi:10.1182/blood.v92.3.802 · Cited by 325
Self-citationZojer, N., Königsberg, R., Ackermann, J., Fritz, E., Dallinger, S., Krömer, E., Kaufmann, H., Riedl, L., Gisslinger, H., Schreiber, S., et al. (2000) · Blood · doi:10.1182/blood.v95.6.1925 · Cited by 321
Self-citationThe recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma
Fonseca, R., Debes-Marun, C. S., Picken, E. B., Dewald, G. W., Bryant, S. C., Winkler, J. M., Blood, E., Oken, M. M., Santana-Dávila, R., González-Paz, N., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0493 · Cited by 296
Self-citationTrudel, S., Li, Z. H., Wei, E., Wiesmann, M., Chang, H., Chen, C., Reece, D., Heise, C., & Stewart, A. K. (2005) · Blood · doi:10.1182/blood-2004-10-3913 · Cited by 289
Self-citationPrognostic Significance of Copy-Number Alterations in Multiple Myeloma
Avet-Loiseau, H., Li, C., Magrangeas, F., Gouraud, W., Charbonnel, C., Harousseau, J.-L., Attal, M., Marit, G., Mathiot, C., Facon, T., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6136 · Cited by 276
Self-citationJagannath, S., Richardson, P. G., Sonneveld, P., Schuster, M. W., Irwin, D., Stadtmauer, E. A., Facon, T., Harousseau, J.-L., Cowan, J. M., & Anderson, K. C. (2007) · Leukemia · doi:10.1038/sj.leu.2404442 · Cited by 264
Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling
Chng, W. J., Kumar, S., VanWier, S., Ahmann, G., Price-Troska, T., Henderson, K., Chung, T.-H., Kim, S., Mulligan, G., Bryant, B., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4046 · Cited by 259
Self-citationLudwig, H., Durie, B. G. M., Bolejack, V., Turesson, I., Kyle, R. A., Blade, J., Fonseca, R., Dimopoulos, M., Shimizu, K., San Miguel, J., et al. (2008) · Blood · doi:10.1182/blood-2007-03-081018 · Cited by 230
Self-citationChromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma
Debes-Marun, C. S., Dewald, G. W., Bryant, S., Picken, E., Santana-Dávila, R., González-Paz, N., Winkler, J. M., Kyle, R. A., Gertz, M. A., Witzig, T. E., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402797 · Cited by 227
Self-citationSawyer, J. R., Tricot, G., Mattox, S., Jagannath, S., & Barlogie, B. (1998) · Blood · doi:10.1182/blood.v91.5.1732 · Cited by 217
Self-citationLiu, P., Leong, T., Quam, L., Billadeau, D., Kay, N., Greipp, P., Kyle, R., Oken, M., & Van Ness, B. (1996) · Blood · doi:10.1182/blood.v88.7.2699.bloodjournal8872699 · Cited by 215
Fonseca, R., Van Wier, S. A., Chng, W. J., Ketterling, R., Lacy, M. Q., Dispenzieri, A., Bergsagel, P. L., Rajkumar, S. V., Greipp, P. R., Litzow, M. R., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404403 · Cited by 213
Self-citationChang, H., Qi, C., Yi, Q.-L., Reece, D., & Stewart, A. K. (2005) · Blood · doi:10.1182/blood-2004-04-1363 · Cited by 201
Self-citationAvet‐Loiseau, H., Facon, T. T. F., Daviet, A., Godon, C., Rapp, M.-J., Harousseau, J., Grosbois, B., & Bataille, R. (1999) · PubMed · Cited by 194
Self-citationChang, H., Sloan, S., Li, D., Zhuang, L., Yi, Q., Chen, C. I., Reece, D., Chun, K., & Keith Stewart, A. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04867.x · Cited by 193
Avet-Loiseau, H., Li, J.-Y., Morineau, N., Facon, T., Brigaudeau, C., Harousseau, J.-L., Grosbois, B., & Bataille, R. (1999) · Blood · doi:10.1182/blood.v94.8.2583.420a05_2583_2589 · Cited by 192
Self-citationGenetic events in the pathogenesis of multiple myeloma
Chng, W. J., Glebov, O., Bergsagel, P. L., & Kuehl, W. M. (2007) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2007.08.004 · Cited by 188
Self-citationWalker, B. A., Leone, P. E., Jenner, M. W., Li, C., Gonzalez, D., Johnson, D. C., Ross, F. M., Davies, F. E., & Morgan, G. J. (2006) · Blood · doi:10.1182/blood-2006-02-005496 · Cited by 187
Self-citationAvet-Loiseau, H., Garand, R., Lodé, L., Harousseau, J.-L., & Bataille, R. (2003) · Blood · doi:10.1182/blood-2002-08-2436 · Cited by 185
Self-citationGutiérrez, N. C., Castellanos, M. V., Martín, M. L., Mateos, M. V., Hernández, J. M., Fernández, M., Carrera, D., Rosiñol, L., Ribera, J. M., Ojanguren, J. M., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404413 · Cited by 185
Fonseca, R., Harrington, D. P., Oken, M. M., Dewald, G. W., Bailey, R. J., Wier, S. A. V., Henderson, K. J., Blood, E., Rajkumar, S. V., Kay, N. E., et al. (2002) · PubMed · Cited by 180
Self-citationBezieau, S., Devilder, M.-C., Avet-Loiseau, H., Mellerin, M.-P., Puthier, D., Pennarun, E., Rapp, M.-J., Harousseau, J.-L., Moisan, J.-P., & Bataille, R. (2001) · Human Mutation · doi:10.1002/humu.1177 · Cited by 180
Self-citationShi, J., Tricot, G. J., Garg, T. K., Malaviarachchi, P. A., Szmania, S. M., Kellum, R. E., Storrie, B., Mulder, A., Shaughnessy, J. D., Barlogie, B., et al. (2008) · Blood · doi:10.1182/blood-2007-03-078535 · Cited by 175
Self-citationTricot, G., Sawyer, J. R., Jagannath, S., Desikan, K. R., Siegel, D., Naucke, S., Mattox, S., Bracy, D., Munshi, N., & Barlogie, B. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.7.2659 · Cited by 172
Self-citationPérez-Simón, J. A., Garcı́a-Sanz, R., Tabernero, M. D., Almeida, J., González, M., Fernández-Calvo, J., Moro, M. J., Hernández, J. M., Miguel, J. F. S., & Orfão, A. (1998) · Blood · doi:10.1182/blood.v91.9.3366 · Cited by 169
Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases
Smadja, N.-V., Fruchart, C., Isnard, F., Louvet, C., Dutel, J.-L., Cheron, N., Grange, M.-J., Monconduit, M., & Bastard, C. (1998) · Leukemia · doi:10.1038/sj.leu.2401041 · Cited by 168
Rasmussen, T., Kuehl, M., Lodahl, M., Johnsen, H. E., & Dahl, I. M. S. (2005) · Blood · doi:10.1182/blood-2004-03-0833 · Cited by 163
Trudel, S., Ely, S., Farooqi, Y., Affer, M., Robbiani, D. F., Chesi, M., & Bergsagel, P. L. (2004) · Blood · doi:10.1182/blood-2003-10-3650 · Cited by 162
Self-citationClinical and biological significance of RAS mutations in multiple myeloma
Chng, W. J., Gonzalez-Paz, N., Price-Troska, T., Jacobus, S., Rajkumar, S. V., Oken, M. M., Kyle, R. A., Henderson, K. J., Van Wier, S., Greipp, P., et al. (2008) · Leukemia · doi:10.1038/leu.2008.142 · Cited by 161
Self-citationChiecchio, L., Protheroe, R. K. M., Ibrahim, A. H., Cheung, K. L., Rudduck, C., Dagrada, G. P., Cabanas, E. D., Parker, T., Nightingale, M., Wechalekar, A., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404304 · Cited by 161
Self-citationHayman, S. R., Bailey, R. J., Jalal, S. M., Ahmann, G. J., Dispenzieri, A. A., Gertz, M. A., Greipp, P. R., Kyle, R. A., Lacy, M. Q., Rajkumar, S. V., et al. (2001) · Blood · doi:10.1182/blood.v98.7.2266 · Cited by 150
Self-citationChng, W. J., Santana-Dávila, R., Wier, S. A. V., Ahmann, G. J., Jalal, S. M., Bergsagel, P. L., Chesi, M., Trendle, M. C., Jacobus, S. J., Blood, E., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404172 · Cited by 145
Self-citationJenner, M. W., Leone, P., Walker, B. A., Ross, F. M., Johnson, D. C., de Castro, D. G., Chiecchio, L., Cabanas, E. D., Dagrada, G. P., Nightingale, M., et al. (2007) · Blood · doi:10.1182/blood-2007-02-075069 · Cited by 143
Self-citationXiong, W., Wu, X., Starnes, S. E., Johnson, S., Haessler, J., Wang, S., Chen, L., Barlogie, B., Shaughnessy, J. D., & Zhan, F. (2008) · Blood · doi:10.1182/blood-2007-10-119123 · Cited by 143
Self-citationFonseca, R., Oken, M., Harrington, D. P., Bailey, R., Wier, S. V., Henderson, K. J., Kay, N. E., Ness, B. V., Greipp, P., & Dewald, G. (2001) · Leukemia · doi:10.1038/sj.leu.2402125 · Cited by 140
Self-citationA validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS
Chng, W. J., Wier, S. A. V., Ahmann, G. J., Winkler, J. M., Jalal, S. M., Bergsagel, P. L., Chesi, M., Trendle, M. C., Oken, M. M., Blood, E., et al. (2005) · Blood · doi:10.1182/blood-2005-02-0761 · Cited by 128
Self-citationDewald, G. W., Therneau, T. M., Larson, D. R., Lee, Y. K., Fink, S. R., Smoley, S. A., Paternoster, S. F., Adeyinka, A., Ketterling, R. P., Dyke, D. L. V., et al. (2005) · Blood · doi:10.1182/blood-2005-05-1981 · Cited by 127
Self-citationChang, H., Sloan, S. R., Li, D., & Stewart, A. K. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05199.x · Cited by 124
Self-citationThe (11;14)(q13;q32) Translocation in Multiple Myeloma
Hoyer, J. D., Hanson, C. A., Fonseca, R., Greipp, P. R., Dewald, G. W., & Kurtin, P. J. (2000) · American Journal of Clinical Pathology · doi:10.1309/4w8e-8f4k-bhup-ube7 · Cited by 122
Self-citationAhmann, G. J., Jalal, S. M., Juneau, A. L., Christensen, E. R., Hanson, C. A., Dewald, G. W., & Greipp, P. R. (1998) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(97)00058-7 · Cited by 119
Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications
Gonzalez-Paz, N. C., Chng, W. J., McClure, R. F., Blood, E., Oken, M. M., Ness, B. V., James, C. D., Kurtin, P. J., Henderson, K. J., Ahmann, G. J., et al. (2006) · Blood · doi:10.1182/blood-2006-05-024661 · Cited by 112
Self-citationChromosome 13 abnormalities in multiple myeloma are mostly monosomy 13
Avet‐Loiseau, H., Daviet, A., Saunier, S., & Bataille, R. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02488.x · Cited by 104
Self-citationSchop, R. F. J., Wier, S. A. V., Xu, R., Ghobrial, I. M., Ahmann, G. J., Greipp, P. R., Kyle, R. A., Dispenzieri, A. A., Lacy, M. Q., Rajkumar, S. V., et al. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2006.04.009 · Cited by 99
Self-citationFonseca, R., Oken, M., & Greipp, P. (2001) · Blood · doi:10.1182/blood.v98.4.1271 · Cited by 97
Self-citationClinical implication of centrosome amplification in plasma cell neoplasm
Chng, W. J., Ahmann, G. J., Henderson, K. J., Santana-Dávila, R., Greipp, P. R., Gertz, M. A., Lacy, M. Q., Dispenzieri, A. A., Kumar, S. K., Rajkumar, S. V., et al. (2005) · Blood · doi:10.1182/blood-2005-09-3810 · Cited by 96
Self-citationSawyer, J. R., Lukacs, J. L., Thomas, E. L., Swanson, C. M., Goosen, L. S., Sammartino, G., Gilliland, J. C., Munshi, N. C., Tricot, G. J. K., Shaughnessy, J. D., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02546.x · Cited by 95
Self-citationMateos, M., García‐Sánz, R., López‐Pérez, R., Moro, M. J., Ocio, E. M., Hernández‐Rivas, J., Megido, M., Caballero, M. D., Fernández‐Calvo, J., Bárez, A., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03749.x · Cited by 79
Schilling, G., Hansen, T., Shimoni, A., Zabelina, T., Simon-Perez, J.-A., Gutierrez, N. C., Bethge, W. A., Liebisch, P., Schwerdtfeger, R., Bornhäuser, M., et al. (2008) · Leukemia · doi:10.1038/leu.2008.88 · Cited by 79
Self-citationChang, H., Qi, X. Y., Samiee, S., Yi, Q., Chen, C., Trudel, S., Mikhael, J. R., Reece, D. E., & Stewart, A. K. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705131 · Cited by 65
Self-citationMethylation of the p16INK4A gene in multiple myeloma
Tasaka, T., Asou, H., Munker, R., Said, J. W., Berenson, J., Vescio, R. A., Nagai, M., Takahara, J., & Koeffler, H. P. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00724.x · Cited by 49
Hypermethylation of p16INK4A gene promoter during the progression of plasma cell dyscrasia
Uchida, T., Kinoshita, T., Ohno, T., Ohashi, H., Nagai, H., & Saito, H. (2001) · Leukemia · doi:10.1038/sj.leu.2401991 · Cited by 48
Brousseau, M., Leleu, X. P., Gerard, J., Gastinne, T., Godon, A., Geneviève, F., Dib, M., Laï, J., Facon, T. T. F., Zandecki, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0031 · Cited by 41
Characterization of p16(INK4A) expression in multiple myeloma and plasma cell leukemia.
Urashima, M., Teoh, G., Ogata, A., et al. (1997) · PubMed · Cited by 35
Chng, W. J., Kuehl, W. M., Bergsagel, P. L., & Fonseca, R. (2007) · Leukemia · doi:10.1038/sj.leu.2404934 · Cited by 34
Self-citationPloidy status rarely changes in myeloma patients at disease progression
Chng, W. J., Winkler, J. M., Greipp, P. R., Jalal, S. M., Bergsagel, P. L., Chesi, M., Trendle, M. C., Ahmann, G. J., Henderson, K. J., Blood, E., et al. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.07.004 · Cited by 32
Self-citationEstablishment and exploitation of hyperdiploid and non‐hyperdiploid human myeloma cell lines
Li, X., Pennisi, A., Zhan, F., Sawyer, J. R., Shaughnessy, J. D., & Yaccoby, S. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06742.x · Cited by 29
Self-citationFonseca, R. (2003) · Leukemia · doi:10.1038/sj.leu.2403090 · Cited by 28
Self-citationMethylation of p16 and p15 genes in multiple myeloma.
Chen, W., Wu, Y., Zhu, J., Liu, J., Tan, S., & Xia, C.-Q. (2002) · PubMed · Cited by 20
Oncogenesis of Multiple Myeloma
Drach, J. W., Seidl, S., Ackermann, J., & Kaufmann, H. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-817-5_4 · Cited by 3
Self-citation
Cited by
Palumbo, A., & Anderson, K. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011442 · Cited by 2,326
Palumbo, A., Avet-Loiseau, H., Oliva, S., Lokhorst, H. M., Goldschmidt, H., Rosinol, L., Richardson, P., Caltagirone, S., Lahuerta, J. J., Facon, T., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.2267 · Cited by 2,210
Self-citationCampo, E., Jaffe, E. S., Cook, J. R., Quintanilla-Martinez, L., Swerdlow, S. H., Anderson, K. C., Brousset, P., Cerroni, L., de Leval, L., Dirnhofer, S., et al. (2022) · Blood · doi:10.1182/blood.2022015851 · Cited by 1,608
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
Lohr, J. G., Stojanov, P., Carter, S. L., Cruz-Gordillo, P., Lawrence, M. S., Auclair, D., Sougnez, C., Knoechel, B., Gould, J., Saksena, G., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.015 · Cited by 988
Self-citationSonneveld, P., Avet-Loiseau, H., Lonial, S., Usmani, S., Siegel, D., Anderson, K. C., Chng, W.-J., Moreau, P., Attal, M., Kyle, R. A., et al. (2016) · Blood · doi:10.1182/blood-2016-01-631200 · Cited by 928
Self-citation
Metadata
- Authors
- Fonseca, R., Bergsagel, P. L., Drach, J., Shaughnessy, J., Gutierrez, N., Stewart, A. K., Morgan, G., Van Ness, B., Chesi, M., Minvielle, S., Neri, A., Barlogie, B., Kuehl, W. M., Liebisch, P., Davies, F., Chen-Kiang, S., Durie, B. G. M., Carrasco, R., Sezer, O., Reiman, T., Pilarski, L., & Avet-Loiseau, H.
- Venue
- Leukemia
- Published
- 2009-10-01
- Volume
- 23
- Issue
- 12
- Pages
- 2210-2221
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2015880063
- Cited by
- 886
- References
- 83
- FWCI
- 40.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.